Southern Maryland’s economic potential lies in the region’s higher education institutions producing highly technical and skilled workers, according to area leaders.
Military officials, educators, business leaders and others discussed Southern Maryland’s potential economic growth Monday during a forum at the Prince Frederick campus of the College of Southern Maryland.
It’s a bit surreal to go to a science fair at a hospital. But the group of health IT companies from DreamIt Venture’s accelerator coupled with demonstrations of technology from Children’s Hospital of Philadelphia and University of Pennsylvania helped set the scene for a new initiative by DreamIt that’s starting at CHOP. The program is designed to help companies and institutions develop enterprise software and commercially viable companies.
DreamIt Ventures’ Open Canvas@CHOP is a one-year program at the pediatric hospital to help it further develop its reputation for pediatric innovation but in enterprise software. The program will also see two teams from the institution take part in DreamIt Health’s next accelerator class in Philadelphia this summer.
An entrepreneurial culture is alive and well in the nation’s capital, bolstered by a wave of successful startups of various shapes and sizes that are creating jobs and improving the world. In pursuing continued economic growth that is not dependent upon federal funds, the D.C. community must focus on encouraging and supporting more entrepreneurs. One clear path to accelerating the evolution of a startup culture, highlighted by the University of Maryland’s recent recognition as the top public university for technology entrepreneurship in the 2013 StartEngine College Index, is through our local institutions of higher education. Their curricula, access to space and technology, and vast alumni networks make universities the perfect home for entrepreneurship, and their efforts to create a new generation of entrepreneurs need our community’s support.
Illumina Inc. is launching what it bills as the world’s first genomics incubator, saying it has teamed up with technology billionaire Yuri Milner and Silicon Valley Bank to invest hundreds of thousands of dollars in startups.
The San Diego maker of genome sequencing equipment said that it plans to offer aspiring genomics businesses both funding and access to lab equipment. Work would take place in the San Francisco Bay Area.
These top venture capitalists don’t wait for biotech startups to come to them. They create companies themselves.
The path to greatness in biotechnology runs through a vale of tears. Mark Levin wants to remember that.
For Marie Johnson, coming up with a better way to detect coronary artery disease is both a business and a personal mission.
Johnson is CEO of AUM Cardiovascular, a Minnesota medical device company that’s developing a potentially cheaper, simpler, eight-minute test to detect signs of coronary artery disease — the primary cause of heart attack.
Just what is a “National Cybersecurity Center of Excellence,” anyway?
I’ve heard this question muttered repeatedly, in one form or another, in the course of covering the ongoing bio vs. cyber dispute over the future of the William Hanna Center for Innovation at Shady Grove.
Cangene Corporation (“Cangene”) (TSX: CNJ) today announced that the Ontario Superior Court of Justice issued a final order approving the Plan of Arrangement for the previously announced acquisition of Cangene by Emergent BioSolutions Inc. (NYSE: EBS). Under the court-approved Plan of Arrangement, Cangene shareholders will receive US$3.24 per share (C$3.56(1) per share) in cash, for an aggregate purchase price of US$222 million (approximately C$244 million(2) ).
Cangene previously announced that the waiting period mandated under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the transaction expired on January 28, 2014. On February 12, 2014, the Plan of Arrangement was approved by approximately 99.95% of the votes cast at a special meeting of Cangene’s common shareholders, which constituted more than 90.1% of the outstanding Cangene common shares.
Federal and Maryland officials signed an agreement on Tuesday with the National Institute of Standards and Technology in Gaithersburg to develop new cyber security technology and provide opportunities for students in the state.
The agreement plans to expand on a February 2012 collaboration agreement signed by NIST, Maryland officials and Montgomery County officials to establish the National Cybersecurity Center of Excellence.
Epidarex Capital, a leading international early-stage life science venture capital fund, has invested in Confluence Life Sciences Inc., a biotechnology company focused on the rapid discovery and development of drugs to address unmet needs in cancer and chronic inflammatory disease.
Confluence’s innovative KINect Technology Platform enables the identification and development of new protein kinase drugs in a fraction of the time of other approaches. Confluence’s team of world-class drug developers has created a pipeline of drug candidates which focus on creating kinase inhibitors targeting hard-to-treat cancers. Confluence’s lead program targets the kinase TAK1, which is important in cancer cell transformation, metastasis, tumor growth and drug resistance, especially in pancreatic and other cancers such as breast and colon.
